This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Title: The Innovative Contributions of Francois Conquet
Introduction
Francois Conquet is a notable inventor based in France. He has made significant strides in the field of pharmaceutical sciences, particularly in the modulation of nervous system receptors. His work focuses on developing compounds that can effectively influence glutamatergic signaling, which is crucial for various neurological functions.
Latest Patents
Francois Conquet holds a patent for a novel chromone oxime derivative, which serves as an allosteric modulator of metabotropic glutamate receptors. This invention presents a unique compound that demonstrates high brain penetration upon oral administration. The pharmaceutical composition derived from this compound is aimed at treating or preventing conditions associated with altered glutamatergic signaling, particularly in acute and chronic neurological and psychiatric disorders.
Career Highlights
Conquet is currently associated with Prexton Therapeutics, a company dedicated to advancing treatments for neurological disorders. His expertise in pharmacology and receptor modulation has positioned him as a key figure in the development of innovative therapeutic solutions.
Collaborations
Francois Conquet has collaborated with notable colleagues such as Vincent Pomel and Baptiste Manteau. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Francois Conquet's contributions to the field of pharmaceutical sciences highlight his innovative approach to addressing complex neurological conditions. His work continues to pave the way for advancements in treatment options for patients suffering from various disorders.